Sign In

Login

Password

Forgot Password ? Sign Up

Спіс нейрастэроідаў (Belarusian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Спіс нейрастэроідаў" in Belarusian language version.

refsWebsite
Global rank Belarusian rank
20nih.gov
4th place
66th place
17doi.org
2nd place
22nd place
3semanticscholar.org
11th place
3,063rd place
1harvard.edu
18th place
75th place
1archive.org
6th place
44th place
1springer.com
274th place
822nd place

archive.org

doi.org

  • Linsenbardt AJ, Taylor A, Emnett CM, Doherty JJ, Krishnan K, Covey DF, Paul SM, Zorumski CF, Mennerick S (2014). "Different oxysterols have opposing actions at N-methyl-D-aspartate receptors". Neuropharmacology. 85: 232–42. doi:10.1016/j.neuropharm.2014.05.027. PMC 4107067. PMID 24878244.
  • Kaminski RM, Marini H, Ortinski PI, Vicini S, Rogawski MA (2006). "The pheromone androstenol (5 alpha-androst-16-en-3 alpha-ol) is a neurosteroid positive modulator of GABAA receptors". J. Pharmacol. Exp. Ther. 317 (2): 694–703. doi:10.1124/jpet.105.098319. PMID 16415088. S2CID 95393004.
  • Kaminski RM, Marini H, Kim WJ, Rogawski MA (2005). "Anticonvulsant activity of androsterone and etiocholanolone". Epilepsia. 46 (6): 819–27. doi:10.1111/j.1528-1167.2005.00705.x. PMC 1181535. PMID 15946323.
  • Belelli D, Lambert JJ, Peters JA, Gee KW, Lan NC (1996). "Modulation of human recombinant GABAA receptors by pregnanediols". Neuropharmacology. 35 (9–10): 1223–31. doi:10.1016/s0028-3908(96)00066-4. PMID 9014137. S2CID 10437944.
  • "Evaluating the neurotherapeutic potential of a water-soluble progesterone analog after traumatic brain injury in rats". Neuropharmacology. 109: 148–158. October 2016. doi:10.1016/j.neuropharm.2016.05.017. PMID 27267687.
  • "Breakthroughs in neuroactive steroid drug discovery". Bioorg. Med. Chem. Lett. 28: 61–70. doi:10.1016/j.bmcl.2017.11.043. PMID 29223589.
  • "Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor". J. Med. Chem. 60: 7810–7819. doi:10.1021/acs.jmedchem.7b00846. PMID 28753313.
  • "Development and screening of water-soluble analogues of progesterone and allopregnanolone in models of brain injury". J. Med. Chem. 52: 6012–23. doi:10.1021/jm900712n. PMID 19791804.
  • "Water-soluble progesterone analogues are effective, injectable treatments in animal models of traumatic brain injury". ACS Med Chem Lett. 3: 362–6. doi:10.1021/ml200303r. PMID 24900479.
  • "Effects of 3-hydrazone modification on the metabolism and protein binding of progesterone". International Journal of Pharmaceutics. 65: 109–114. doi:10.1016/0378-5173(90)90015-V.
  • "Synthesis and kinetic stability studies of progesterone derivatives". International Journal of Pharmaceutics. 47: 195–203. doi:10.1016/0378-5173(88)90231-1.
  • Paul SM, Doherty JJ, Robichaud AJ, Belfort GM, Chow BY, Hammond RS, Crawford DC, Linsenbardt AJ, Shu HJ, Izumi Y, Mennerick SJ, Zorumski CF (2013). "The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors". J. Neurosci. 33 (44): 17290–300. doi:10.1523/JNEUROSCI.2619-13.2013. PMC 3812502. PMID 24174662.
  • Hénin J, Salari R, Murlidaran S, Brannigan G (2014). "A predicted binding site for cholesterol on the GABAA receptor". Biophys. J. 106 (9): 1938–49. Bibcode:2014BpJ...106.1938H. doi:10.1016/j.bpj.2014.03.024. PMC 4017285. PMID 24806926.
  • Levitan I, Singh DK, Rosenhouse-Dantsker A (2014). "Cholesterol binding to ion channels". Front Physiol. 5: 65. doi:10.3389/fphys.2014.00065. PMC 3935357. PMID 24616704.
  • Lange Y, Steck TL (2016). "Active membrane cholesterol as a physiological effector". Chem. Phys. Lipids. 199: 74–93. doi:10.1016/j.chemphyslip.2016.02.003. PMID 26874289.
  • Nozawa Y, Sakai N, Matsumoto K, Mizoue K (2002). "A novel neuritogenic compound, NGA0187". J. Antibiot. 55 (7): 629–34. doi:10.7164/antibiotics.55.629. PMID 12243452.
  • Papadopoulos V, Lecanu L (2012). "Caprospinol: discovery of a steroid drug candidate to treat Alzheimer's disease based on 22R-hydroxycholesterol structure and properties". J. Neuroendocrinol. 24 (1): 93–101. doi:10.1111/j.1365-2826.2011.02167.x. PMID 21623958. S2CID 24032303.

harvard.edu

ui.adsabs.harvard.edu

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Linsenbardt AJ, Taylor A, Emnett CM, Doherty JJ, Krishnan K, Covey DF, Paul SM, Zorumski CF, Mennerick S (2014). "Different oxysterols have opposing actions at N-methyl-D-aspartate receptors". Neuropharmacology. 85: 232–42. doi:10.1016/j.neuropharm.2014.05.027. PMC 4107067. PMID 24878244.
  • Kaminski RM, Marini H, Ortinski PI, Vicini S, Rogawski MA (2006). "The pheromone androstenol (5 alpha-androst-16-en-3 alpha-ol) is a neurosteroid positive modulator of GABAA receptors". J. Pharmacol. Exp. Ther. 317 (2): 694–703. doi:10.1124/jpet.105.098319. PMID 16415088. S2CID 95393004.
  • Kaminski RM, Marini H, Kim WJ, Rogawski MA (2005). "Anticonvulsant activity of androsterone and etiocholanolone". Epilepsia. 46 (6): 819–27. doi:10.1111/j.1528-1167.2005.00705.x. PMC 1181535. PMID 15946323.
  • Belelli D, Lambert JJ, Peters JA, Gee KW, Lan NC (1996). "Modulation of human recombinant GABAA receptors by pregnanediols". Neuropharmacology. 35 (9–10): 1223–31. doi:10.1016/s0028-3908(96)00066-4. PMID 9014137. S2CID 10437944.
  • "Evaluating the neurotherapeutic potential of a water-soluble progesterone analog after traumatic brain injury in rats". Neuropharmacology. 109: 148–158. October 2016. doi:10.1016/j.neuropharm.2016.05.017. PMID 27267687.
  • "Breakthroughs in neuroactive steroid drug discovery". Bioorg. Med. Chem. Lett. 28: 61–70. doi:10.1016/j.bmcl.2017.11.043. PMID 29223589.
  • "Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor". J. Med. Chem. 60: 7810–7819. doi:10.1021/acs.jmedchem.7b00846. PMID 28753313.
  • "Development and screening of water-soluble analogues of progesterone and allopregnanolone in models of brain injury". J. Med. Chem. 52: 6012–23. doi:10.1021/jm900712n. PMID 19791804.
  • "Water-soluble progesterone analogues are effective, injectable treatments in animal models of traumatic brain injury". ACS Med Chem Lett. 3: 362–6. doi:10.1021/ml200303r. PMID 24900479.
  • Paul SM, Doherty JJ, Robichaud AJ, Belfort GM, Chow BY, Hammond RS, Crawford DC, Linsenbardt AJ, Shu HJ, Izumi Y, Mennerick SJ, Zorumski CF (2013). "The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors". J. Neurosci. 33 (44): 17290–300. doi:10.1523/JNEUROSCI.2619-13.2013. PMC 3812502. PMID 24174662.
  • Hénin J, Salari R, Murlidaran S, Brannigan G (2014). "A predicted binding site for cholesterol on the GABAA receptor". Biophys. J. 106 (9): 1938–49. Bibcode:2014BpJ...106.1938H. doi:10.1016/j.bpj.2014.03.024. PMC 4017285. PMID 24806926.
  • Levitan I, Singh DK, Rosenhouse-Dantsker A (2014). "Cholesterol binding to ion channels". Front Physiol. 5: 65. doi:10.3389/fphys.2014.00065. PMC 3935357. PMID 24616704.
  • Lange Y, Steck TL (2016). "Active membrane cholesterol as a physiological effector". Chem. Phys. Lipids. 199: 74–93. doi:10.1016/j.chemphyslip.2016.02.003. PMID 26874289.
  • Nozawa Y, Sakai N, Matsumoto K, Mizoue K (2002). "A novel neuritogenic compound, NGA0187". J. Antibiot. 55 (7): 629–34. doi:10.7164/antibiotics.55.629. PMID 12243452.
  • Papadopoulos V, Lecanu L (2012). "Caprospinol: discovery of a steroid drug candidate to treat Alzheimer's disease based on 22R-hydroxycholesterol structure and properties". J. Neuroendocrinol. 24 (1): 93–101. doi:10.1111/j.1365-2826.2011.02167.x. PMID 21623958. S2CID 24032303.

ncbi.nlm.nih.gov

  • Linsenbardt AJ, Taylor A, Emnett CM, Doherty JJ, Krishnan K, Covey DF, Paul SM, Zorumski CF, Mennerick S (2014). "Different oxysterols have opposing actions at N-methyl-D-aspartate receptors". Neuropharmacology. 85: 232–42. doi:10.1016/j.neuropharm.2014.05.027. PMC 4107067. PMID 24878244.
  • Kaminski RM, Marini H, Kim WJ, Rogawski MA (2005). "Anticonvulsant activity of androsterone and etiocholanolone". Epilepsia. 46 (6): 819–27. doi:10.1111/j.1528-1167.2005.00705.x. PMC 1181535. PMID 15946323.
  • Paul SM, Doherty JJ, Robichaud AJ, Belfort GM, Chow BY, Hammond RS, Crawford DC, Linsenbardt AJ, Shu HJ, Izumi Y, Mennerick SJ, Zorumski CF (2013). "The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors". J. Neurosci. 33 (44): 17290–300. doi:10.1523/JNEUROSCI.2619-13.2013. PMC 3812502. PMID 24174662.
  • Hénin J, Salari R, Murlidaran S, Brannigan G (2014). "A predicted binding site for cholesterol on the GABAA receptor". Biophys. J. 106 (9): 1938–49. Bibcode:2014BpJ...106.1938H. doi:10.1016/j.bpj.2014.03.024. PMC 4017285. PMID 24806926.
  • Levitan I, Singh DK, Rosenhouse-Dantsker A (2014). "Cholesterol binding to ion channels". Front Physiol. 5: 65. doi:10.3389/fphys.2014.00065. PMC 3935357. PMID 24616704.

semanticscholar.org

api.semanticscholar.org

springer.com

adisinsight.springer.com